Drug Experts Concerned About Increased Chinese-Drug Exports To U.S., Europe (China)
This article was originally published in PharmAsia News
Executive Summary
Pharmaceutical companies in China have doubled their exports to the United States in the past five years, and some industry experts are raising national-security concerns. They note that the ingredients for anthrax vaccines no longer exist in the West, leaving the area to rely on China and India to produce the drugs after Western supplies are exhausted. There also are concerns about the safety of Chinese factories and the long-term stability of trade between China, and U.S. European industry experts voice similar national-security concerns. (Click here for more